Crispr Therapeutics Ag (CRSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 0 | 70,000 | 100,000 | 6 | 94 |
| Gross Profit | N/A | 70,000 | 100,000 | 6 | 94 |
| Operating Expenses | 132,411 | 165,223 | 164,487 | 131,547 | 182,482 |
| Operating Income | -132,411 | -95,223 | -64,487 | -131,541 | -182,388 |
| Other Income | 20,671 | 18,406 | 12,742 | 11,490 | 7,264 |
| Pre-tax Income | -111,740 | -76,817 | -51,745 | -120,051 | -175,124 |
| Income Tax | 412 | 923 | 1,320 | -9,476 | -575 |
| Net Income Continuous | -112,152 | -77,740 | -53,065 | -110,575 | -174,549 |
| Net Income | $-112,152 | $-77,740 | $-53,065 | $-110,575 | $-174,549 |
| EPS Basic Total Ops | -1.41 | -0.98 | -0.67 | -1.40 | -2.24 |
| EPS Basic Continuous Ops | -1.41 | -0.98 | -0.67 | -1.40 | -2.24 |
| EPS Diluted Total Ops | -1.41 | -0.98 | -0.67 | -1.40 | -2.24 |
| EPS Diluted Continuous Ops | -1.41 | -0.98 | -0.67 | -1.40 | -2.24 |
| EBITDA(a) | $-127,486 | $-90,262 | $-59,436 | $-125,695 | $-177,370 |